Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05304494

Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Sanome · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The Sentinel-001 study aims to identify a combination of biomarkers suitable for triage of breathlessness.

Conditions

Interventions

TypeNameDescription
OTHERBiomarker tests for participant profilingCombination of digital and physical tests to objectify measures relevant for breathlessness

Timeline

Start date
2022-03-01
Primary completion
2024-03-01
Completion
2024-03-01
First posted
2022-03-31
Last updated
2022-05-13

Source: ClinicalTrials.gov record NCT05304494. Inclusion in this directory is not an endorsement.

Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers (NCT05304494) · Clinical Trials Directory